PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

295 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... 11 ... 12 ... 13 ... 14 ... 15 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
41.
Lorza-Gil, E. et al.: Glucose-stimulated insulin secretion depends on FFA1 and Gq in neonatal mouse islets. Diabetologia 66, 1501-1515 (2023)
42.
Luo, H. et al.: Associations of plasma proteomics with type 2 diabetes and related traits: Results from the longitudinal KORA S4/F4/FF4 Study. Diabetologia 66, 1655-1668 (2023)
43.
Lutter, D. et al.: Skeletal muscle and intermuscular adipose tissue gene expression profiling identifies new biomarkers with prognostic significance for insulin resistance progression and intervention response. Diabetologia 66, 873-883 (2023)
44.
Marzinotto, I.* et al.: Islet Autoantibody Standardization Program: Interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops. Diabetologia 66, 897-912 (2023)
45.
Nauck, M.A.* & Müller, T.D.: Incretin hormones and type 2 diabetes. Diabetologia 66, 1780-1795 (2023)
46.
Tschöp, M.H. ; Nogueiras, R.* & Ahrén, B.*: Gut hormone-based pharmacology: Novel formulations and future possibilities for metabolic disease therapy. Diabetologia 66, 1796-1808 (2023)
47.
Wewer Albrechtsen, N.J.* et al.: 100 years of glucagon and 100 more. Diabetologia 66, 1378-1394 (2023)
48.
Ziegler, A.-G.: The countdown to type 1 diabetes: when, how and why does the clock start? Diabetologia 66, 1169-1178 (2023)
49.
Fraszczyk, E.* et al.: Epigenome-wide association study of incident type 2 diabetes: A meta-analysis of five prospective European cohorts. Diabetologia 65, 763-776 (2022)
50.
Maalmi, H.* et al.: Serum neurofilament light chain: A novel biomarker for early diabetic sensorimotor polyneuropathy. Diabetologia 66, 579-589 (2022)
51.
Meyhöfer, S.* et al.: Sleep deprivation prevents counterregulatory adaptation to recurrent hypoglycaemia. Diabetologia 65, 1212-1221 (2022)
52.
Morgenstern, J.* et al.: Correction to: Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy. Diabetologia 65:257 (2022)
53.
Ng, K.* et al.: Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children. Diabetologia 66, 93-104 (2022)
54.
Sola-Gazagnes, A.* et al.: Insulin allergy: A diagnostic and therapeutic strategy based on a retrospective cohort and a case–control study. Diabetologia 65, 1278-1290 (2022)
55.
Weiss, A. et al.: Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening. Diabetologia 65, 93-104 (2022)
56.
Weiss, A. et al.: Correction to: Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening. Diabetologia, DOI: 10.1007/s00125-022-05798-z (2022)
57.
Woelfle, T.* et al.: Health impact of seven herpesviruses on (pre)diabetes incidence and HbA1c: Results from the KORA cohort. Diabetologia 65, 1328-1338 (2022)
58.
Assfalg, R. et al.: Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial. Diabetologia 64, 1079-1092 (2021)
59.
Bediaga, N.G.* et al.: Simplifying prediction of disease progression in pre-symptomatic type 1 diabetes using a single blood sample. Diabetologia, DOI: 10.1007/s00125-021-05523-2 (2021)
60.
Gar, C. et al.: The liver–alpha cell axis associates with liver fat and insulin resistance: A validation study in women with non-steatotic liver fat levels. Diabetologia 64, 512-520 (2021)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... 11 ... 12 ... 13 ... 14 ... 15 ... ▶▶ ▶▮